Dhatakyadi Varti-An Advance Therapy for Vulvovaginitis During Pregnancy
Phase 1
Completed
- Registration Number
- CTRI/2015/05/005747
- Lead Sponsor
- IPGTRA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 46
Inclusion Criteria
1.The pregnant women with different parity having signs and symptoms of vulvovaginitis.
2.Age 19 to 40years.
3.White discharge present during examination.
4.Inflammation present in vulva and vagina.
5.Pathogens present in wet slide study and vaginal swab culture.
Exclusion Criteria
1.Non pregnant Women.
2.Age below 19yrs or above 40 yrs
3.Hypersensitivity to drug and inability to conform the protocol.
4.Women with severe Physical illness, any systemic disease like D.M.,any organic Pathology, Hepatic, Cardiac, Renal disease and any acute Infection of any system,
5.Women suffering from disease like S.T.D.,H.I.V.etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PATIENT GOT SYMPTOMATIC RELIVE IN BOTH GROUPSTimepoint: AFTER 14 DAYS OF TREATMENT
- Secondary Outcome Measures
Name Time Method TO PREVENT COMPLICATION LIKE PRE MATURE RUPTURE OF MEMBRANE AND PRE TERM LABORTimepoint: TO PREVENT COMPLICATION LIKE PRE MATURE RUPTURE OF MEMBRANE AND PRE TERM LABOR